Form 4 for MRKR Marker Therapeutics, Inc.
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-24 · accession 0001209191-22-021396 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-28 | 2022-03-24 | MRKR | Hoang Peter L. | Pres, CEO, Dir | A - Grant | $0.00 | +199.1K | 531.7K | +60% | $0 | |
| 2022-03-28 | 2022-03-24 | MRKR | Hoang Peter L. | Pres, CEO, Dir | F - Tax | $0.48 | -48.4K | 483.3K | -9% | -$23.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-24 | A | A | 199,094 | $0.00 | 531,662 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. |
| 2 | Common | Common Stock | 2022-03-24 | F | D | 48,376 | $0.48 | 483,286 | D | — | — | (F2) Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs. |